Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults With Chronic Plaque Psoriasis From a 52-Week, Phase 2 Open-Label Safety Trial. J of Skin [Internet]. 2023 Jul. 17 [cited 2025 Apr. 18];7(4):s218. Available from: https://skin.dermsquared.com/skin/article/view/2194